Biotech Startups
9,920 companies tagged Biotech, with their investors and founders.
First Spark Ventures is a venture capital firm that invests in deep tech startups focused on advanced compute, digital biology and biotech, and cyber-physical systems. It backs companies at pre-seed, seed, and Series A stages and partners with SRI International.
2 investors
2 investors
FLOWBIO makes a wearable sweat sensor and companion app that continuously measure an athlete's fluid and sodium loss and turn the data into personalized hydration and rehydration plans. Aimed at athletes and performance centres, the system streams real-time data to devices like Wahoo, Garmin, COROS and Zwift and has been validated in a peer-reviewed study.
2 investors
2 investors
FluoretiQ develops rapid point-of-care diagnostic tools that identify bacteria and determine effective antibiotics for veterinarians and clinicians, aiming to reduce reliance on empirical antibiotic treatment. Its NANOPLEX latex agglutination platform underpins its first product, VERI-5 VET, and its SCFI platform provides growth-free antibiotic susceptibility testing.
2 investors
FluoSphera develops in vitro human biology solutions for drug discovery, applying translational research to improve preclinical decision-making. The company serves pharmaceutical and biotech organizations seeking more predictive biological models.
2 investors
FogPharma develops ultra-tunable Helicon peptide therapeutics designed to reach historically undruggable targets, aiming to treat cancer and other serious diseases. The company operates a custom-built research platform focused on this peptide modality for drug discovery.
2 investors
A venture capital firm investing in biotech companies across all stages of pharmaceutical development, and in sustainable solutions across food, agriculture, materials, and environmental technologies through its BioEconomy strategy.
2 investors
Forcefield Therapeutics develops cardioprotective proteins for the treatment of cardiac disease, with an initial focus on myocardial infarction (heart attack). It holds an exclusive licence to these proteins and operates a virtual business model working with strategic and operational partners.
2 investors
Formo uses precision fermentation to produce bio-identical milk proteins (casein) for making animal-free dairy products such as cheese. It supplies these fermentation-derived proteins to enable next-generation dairy foods with the functionality and taste of conventional dairy.
2 investors
For Seafoods develops organoid technology to cultivate seafood at scale, offering a sustainable alternative to ocean fishing. The company's proprietary tissue formation method reduces production costs and enables commercially viable cultivated seafood for global consumers.
2 investors
FortePhest is a biotechnology company developing crop protection products, including its development-stage herbicide H-Forte, which uses a new mechanism of action targeting the enzyme Phenylalanine tRNA Synthetase to control both regular and herbicide-resistant weeds. Founded in 2017 and based on research from Cornell University, the Weizmann Institute of Science, and the Hebrew University of Jerusalem, it serves the agricultural crop protection market.
2 investors
Francis Medical is a medical device company developing minimally invasive urological cancer treatments using water vapor ablation technology, initially focused on prostate cancer with its Vanquish Water Vapor Ablation System. It plans to expand into bladder and kidney cancer applications, aiming to reduce the side effects associated with conventional prostate treatments.
2 investors
Fraunhofer is a research organization whose Institute for Toxicology and Experimental Medicine (ITEM) conducts contract research, including cell-based in vitro inhalation methods to assess respiratory effects of aerosols and identify potentially harmful substances without animal testing. Its work supports safe product development under a safe-by-design approach.
2 investors
Funga restores forest soil microbiomes by reintroducing native, growth-promoting fungal communities to degraded land, aiming to speed forest growth and increase carbon captured in wood biomass. It uses biodiversity restoration as a carbon-removal climate solution.
2 investors
Future Fertility develops an artificial intelligence tool to assess egg quality for fertility treatment using machine learning analysis of oocyte health. The company serves reproductive endocrinologists, embryologists, and patients undergoing IVF procedures.
2 investors
Gain Therapeutics develops therapeutics using allosteric innovation approaches.
2 investors
2 investors
Galera Therapeutics is a biotechnology company developing antibody-based and other therapeutics. This page profiles Dr. Nancy Chang, a member of the company's Board of Directors.
2 investors
Isolation Bio (Galt Inc.) develops the Prospector Discovery Platform, a high-throughput, automated microbial cultivation array technology that isolates, cultivates, and screens thousands of microbes in parallel. It also offers a microbial isolation and cultivation service for researchers working on microbiome applications in human health, animal health, crop improvement, and environmental health.
2 investors
GelMEDIX is a Cambridge-based biotech developing injectable hydrogel-based cell and gene therapies for vision-restoring retinal treatment.
2 investors
GelSana Therapeutics develops zwitterionic polymer-based biomaterials for wound care, addressing excess sustained inflammation that impedes healing. Its first product, CleraFlex, is a shelf-stable wound dressing designed to reduce inflammation, repel bacteria, balance moisture, and provide a protective barrier.
2 investors
Gencove provides direct-to-consumer genetic sequencing and polygenic risk scoring for health insights. The service analyzes DNA samples to deliver personalized health recommendations across core health areas, ancestry information, and integrates with labs, wearables, and lifestyle data.
2 investors
Gene S is an Australian biotechnology company providing Next Generation Sequencing solutions and gene testing software to laboratories and healthcare providers for delivering pharmacogenomic results.
2 investors